← SynDRA
T-62
SynDRA canonical compound SYN0002746 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ADORA2A |
|---|
| Mechanism of action | adenosine receptor modulator |
|---|
All known targets
Mechanisms of action (all sources)
- ADORA1 MODULATOR
- Adenosine A1 receptor modulator
- ADORA2A ANTAGONIST
Cross-references
Synonyms
- T62
- UNII-9Q765ZIF8L
- CHEMBL57997
- 9Q765ZIF8L
- 3-(4-chlorobenzoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-amine
- (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)(4-chlorophenyl)methanone
- 2-Amino-3-(4-chlorobenzoyl)-5,6,7,8-tetrahydrobenzothiophene
- (2-amino-4,5,6,7-tetrahydro-1-benzothien-3-yl)(4-chlorophenyl)methanone
- (2-Amino-4,5,6,7-tetrahydro-benzo[b]thiophen-3-yl)-(4-chloro-phenyl)-methanone
- BAS 01842965
- AC1Q50OD
- AC1LH2S9
- Oprea1_104969
- Oprea1_077736
- SCHEMBL135569
- CTK6G9061
- DTXSID20193322
- RefChem:492830
- Adenosine A1 receptor activator T62
- A1R enhancer T62
- orb1308689
- orb3033096
- OTZVBZFYMFTYKH-UHFFFAOYSA-N
- GLXC-06779
- QBA31234
- BDBM50080540
- EBC-06837
- EX-A14810
- MFCD02738687
- AKOS000591044
- T62, >=98% (HPLC), crystalline
- NCGC00165911-01
- AS-16827
- DA-78152
- ST080935
- HY-106199
- CS-0025214
- NS00068295
- EN300-11598
Look up T-62 in the interactive SynDRA portal →